VESPER-2 is a 28-week Phase 2b clinical trial assessing the efficacy and tolerability of different weekly doses of MET-097i with or without titration. The trial enrolled the first participant in March ...

Dow Jones futures fell slightly early Wednesday, along with S&P 500 futures and Nasdaq futures. Key economic data before the open will give an early signal as to whether Trump tariffs and tariff ...